We are proud to inform you that DQA and our local parntner in Algeria, Sudomap SARL, have found a strong partner in POLPHARMA SA
Polpharma is our Polish partner in Algeria for API’s, finished dosage forms and Technical/registration dossiers.
Polpharma is the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. They actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia. For over 80 years, they have been trusted by patients, healthcare professionals and business partners alike.
Polpharma is among the top 20 generic drug manufacturers in the world. They employ more than 7,000 people in Poland and on international markets. They have 7 manufacturing plants in Poland, Russia and Kazakhstan, and 7 research and development centres. Polpharma Group’s portfolio includes about 600 products, and another 200 are being developed.
Polpharma manufactures a wide range of prescription drugs and pharmaceuticals for in-patient care. They have a leading share in the key therapeutic areas in Poland. They specialize in pharmaceutical preparations used in cardiology, gastroenterology and neurology. Over the counter medications (OTC) account for a significant part of their product portfolio. In addition, they offer comprises dietary supplements, medical devices, cosmetic products and phyto-pharmaceuticals. They develop their operations in the field of biotechnological drugs: biosimilars.
Polphamra is also one of the largest Polish manufacturers of active pharmaceutical ingredients (APIs) which compete successfully in the developed markets of the EU and the US.
Polpharma provides drugs of the highest quality and reliable medical knowledge. They are one of the most innovative companies in Poland according to the ranking prepared by the Institute of Economic Sciences of the Polish Academy of Sciences (PAN). They contribute to scientific development and health education and promotion.
For more information:
please see: www.polpharma.pl